Barinthus Biotherapeutics plc. Quarterly Operating Income (Loss) in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Barinthus Biotherapeutics plc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q3 2024.
  • Barinthus Biotherapeutics plc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$9.38M, a 41.8% increase year-over-year.
  • Barinthus Biotherapeutics plc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$64.6M, a 27.5% increase year-over-year.
  • Barinthus Biotherapeutics plc. annual Operating Income (Loss) for 2023 was -$83.9M, a 1977% decline from 2022.
  • Barinthus Biotherapeutics plc. annual Operating Income (Loss) for 2022 was -$4.04M, a 91.1% increase from 2021.
  • Barinthus Biotherapeutics plc. annual Operating Income (Loss) for 2021 was -$45.2M, a 126% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$64.6M -$9.38M +$6.73M +41.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$71.3M -$18.3M +$8.05M +30.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$79.3M -$16.9M +$4.57M +21.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$83.9M -$20M +$5.18M +20.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 -$89.1M -$16.1M -$23.3M -323% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$65.8M -$26.3M -$39.6M -299% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$26.2M -$21.5M -$22.1M -3385% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$4.04M -$25.2M -$8.5M -51% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 $4.46M $7.24M +$12.8M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$8.32M $13.2M +$30.1M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$38.4M $654K +$6.83M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$45.2M -$16.7M -$7.04M -73% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 -$38.2M -$5.54M -$4.11M -288% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$34.1M -$16.8M -$12.5M -288% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$21.6M -$6.17M -$1.52M -32.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$20M -$9.63M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 -$1.43M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$4.34M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$4.65M Jan 1, 2020 Mar 31, 2020 10-Q 2021-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.